[EN] NOVEL CHROMEN-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS [FR] NOUVEAUX DERIVES DE CHROMENE-2-ONE ET LEUR UTILISATION COMME INHIBITEURS DE RECAPTURE DU NEUROTRANSMETTEUR MONOAMINE
[EN] NOVEL CHROMEN-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS [FR] NOUVEAUX DERIVES DE CHROMENE-2-ONE ET LEUR UTILISATION COMME INHIBITEURS DE RECAPTURE DU NEUROTRANSMETTEUR MONOAMINE
Novel Chromen-2-One Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
申请人:Peters Dan
公开号:US20070232666A1
公开(公告)日:2007-10-04
This invention relates to novel chromen-2-one derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
CHROMEN-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
申请人:Peters Dan
公开号:US20100056562A1
公开(公告)日:2010-03-04
This invention relates to novel chromen-2-one derivatives useful as monoamine neurotransmitter re-uptake inhibitors.
In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
申请人:Peters Dan
公开号:US08410271B2
公开(公告)日:2013-04-02
This invention relates to chromen-2-one derivatives useful as monoamine neurotransmitter re-uptake inhibitors.
In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
申请人:NeuroSearch AS
公开号:EP2284170A1
公开(公告)日:2011-02-16
This invention relates to novel chromen-2-one derivatives useful as monoamine neurotransmitter re-uptake inhibitors.
In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.